Review of Mankind Pharma IPO
    Whether you should apply in Mankind Pharma IPO?
    The management has formed habit of very fast and impressive growth. Highly capable of developing strong brands in Pharma and FMCG businesses. Grown organically and is the youngest company among the five largest pharmaceutical companies in India, in terms of Domestic Sales in the Financial Year 2022. At a first glance, the price may appear to be high, grey market fancy is also not so strong and yet, the IPO is very very reasonably price and will bring in impressive returns if you remain invested for 9 months.
    Apply with full force.
    Listing gains are also expected.

    Leave a Reply

    Your email address will not be published. Required fields are marked *